Wakita, Masahito <br/><br/>
Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Feb 2014 
 - 246-59 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.113.208751  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Action Potentials--drug effects<br/>Animals<br/>Anticonvulsants--pharmacology<br/>CA3 Region, Hippocampal--cytology<br/>Cells, Cultured<br/>Chelating Agents--pharmacology<br/>Evoked Potentials--drug effects<br/>Female<br/>GABA-A Receptor Agonists--pharmacology<br/>GABA-A Receptor Antagonists--pharmacology<br/>GABAergic Neurons--cytology<br/>Levetiracetam<br/>Male<br/>Mossy Fibers, Hippocampal--drug effects<br/>Nerve Tissue Proteins--agonists<br/>Neural Inhibition--drug effects<br/>Piracetam--analogs & derivatives<br/>Presynaptic Terminals--drug effects<br/>Rats<br/>Receptors, GABA-A--chemistry<br/>Zinc--chemistry